,19In vivo studies found that pexidartinib/PTX treatment led to a remarkable reduction in CD31+ vascular density within mammary tumors and induced apoptosis and necrosis of tumor cells in the MMTV-PyMT mouse model of breast cancer.7 This evidence concerns the gene PECAM1 and breast cancer.